chromogranin a

Plasma chromogranin A after severe burn trauma.
Lindahl A.E., Low A., Stridsberg M., Sjoberg F., Ekselius L., Gerdin B.
Neuropeptides 4
Plasma chromogranin A after severe burn trauma.
Lindahl A.E., Low A., Stridsberg M., Sjoberg F., Ekselius L., Gerdin B.
Neuropeptides 47:207-212(2013) · Mapped (3)
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
Biondi A., Malaguarnera G., Vacante M., Berretta M., D’Agata V., Malaguarnera M., Basile F., Drago F., Bertino G.
BMC Surg 12 Suppl 1:S7-S7(2012) · Mapped (3)
Chromogranin peptides in amyotrophic lateral sclerosis.
Schrott-Fischer A., Bitsche M., Humpel C., Walcher C., Maier H., Jellinger K., Rabl W., Glueckert R., Marksteiner J.
Regul. Pept. 152:13-21(2009) · Mapped (8)
Chromogranin A and the tumor microenvironment.
Corti A.
Cell. Mol. Neurobiol. 30:1163-1170(2010) · Mapped (3)
Chromogranin A and derived peptides in health and disease.
Loh Y.P., Cheng Y., Mahata S.K., Corti A., Tota B.
J. Mol. Neurosci. 48:347-356(2012) · Mapped (3)
[Expression of chromogranin A in human mammary tissues].
Chen Y.X., Li L.H., Sun J., Wang B., Wang L.X.
Nan Fang Yi Ke Da Xue Xue Bao 30:547-548(2010) · Mapped (3)
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B., Gustafsson B.I., Kidd M., Pavel M., Svejda B., Modlin I.M.
Endocrinol. Metab. Clin. North Am. 40:111-134(2011) · Mapped (3)
Chromogranin A cell density as a diagnostic marker for lymphocytic colitis.
El-Salhy M., Gundersen D., Hatlebakk J.G., Hausken T.
Dig. Dis. Sci. 57:3154-3159(2012) · Mapped (3)
Chromogranin A polymorphisms are associated with hypertensive renal disease.
Salem R.M., Cadman P.E., Chen Y., Rao F., Wen G., Hamilton B.A., Rana B.K., Smith D.W., Stridsberg M., Ward H.J. et al.
J. Am. Soc. Nephrol. 19:600-614(2008) · Mapped (6)
Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors.
Warner R.R., Curran T., Shafir M.K., Schiano T.D., Khaitova V., Kim M.K.
Pancreas 40:622-626(2011) · Mapped (3)
Circadian rhythm of human salivary chromogranin A.
Den R., Toda M., Nagasawa S., Kitamura K., Morimoto K.
Biomed. Res. 28:57-60(2007) · Mapped (3)
Chromogranin A and vesicular monoamine transporter 2 immunolocalization in protein bodies of human locus coeruleus neurons.
Kloukina-Pantazidou I., Chrysanthou-Piterou M., Havaki S., Issidorides M.R.
Ultrastruct Pathol 37:102-109(2013) · Mapped (6)
Chromogranin A: a novel susceptibility gene for essential hypertension.
Sahu B.S., Sonawane P.J., Mahapatra N.R.
Cell. Mol. Life Sci. 67:861-874(2010) · Mapped (3)
Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma.
Kimura N., Yoshida R., Shiraishi S., Pilichowska M., Ohuchi N.
Endocr. Pathol. 13:117-122(2002) · Mapped (6)
Correlation between age and Chromogranin A determination in prostate diseases.
Mearini L., Zucchi A., Scarponi E., Nunzi E., Aglietti M.C., Bini V., Porena M.
Cancer Biomark 10:117-123(2011) · Mapped (3)
Extreme exercise enhances chromogranin A levels correlating with stress levels but not with cardiac burden.
Nickel T., Vogeser M., Emslander I., David R., Heilmeier B., Op den Winkel M., Schmidt-Trucksass A., Wilbert-Lampen U., Hanssen H., Halle M.
Atherosclerosis 220:219-222(2012) · Mapped (3)
Chromogranin A is an autoantigen in type 1 diabetes.
Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F. et al.
Nat. Immunol. 11:225-231(2010) · Mapped (2)
Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients.
Chou W.C., Hung Y.S., Hsu J.T., Chen J.S., Lu C.H., Hwang T.L., Rau K.M., Yeh K.Y., Chen T.C., Sun C.F.
Neuroendocrinology 95:344-350(2012) · Mapped (3)
Comparative effect of finasteride and dutasteride on chromogranin A levels.
Sciarra A., Salciccia S., Nesi G., Cattarino S., Alfarone A., Gentilucci A., Gentile V.
Anticancer Res. 30:4737-4742(2010) · Mapped (3)
Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism.
Seccia T.M., Miotto D., De Toni R., Maniero C., Vincenzi M., Motta R., Pessina A.C., Rossi G.P.
J. Clin. Endocrinol. Metab. 96:E825-9(2011) · Mapped (3)
Plasma chromogranin a in patients with inflammatory bowel disease.
Sciola V., Massironi S., Conte D., Caprioli F., Ferrero S., Ciafardini C., Peracchi M., Bardella M.T., Piodi L.
Inflamm. Bowel Dis. 15:867-871(2009) · Mapped (3)
Serum chromogranin A concentration in hyperthyroidism before and after medical treatment.
Al-Shoumer K.A., Vasanthy B.A.
J. Clin. Endocrinol. Metab. 94:2321-2324(2009) · Mapped (3)
Spatio-temporal expression of chromogranin A during zebrafish embryogenesis.
Xie J., Wang W.Q., Liu T.X., Deng M., Ning G.
J. Endocrinol. 198:451-458(2008) · Mapped (4)
Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
Nunzi M.G., Mugnaini E.
Neuroscience 162:673-687(2009) · Mapped (30)
Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
Donica H., Malecha-Jedraszek A., Stroslawska E., Burska A., Szubstarski F.
Folia Histochem. Cytobiol. 48:603-610(2010) · Mapped (3)
Plasma chromogranin A after severe burn trauma.
Lindahl A.E., Low A., Stridsberg M., Sjoberg F., Ekselius L., Gerdin B.
Neuropeptides 47:207-212(2013) · Mapped (3)
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
Biondi A., Malaguarnera G., Vacante M., Berretta M., D’Agata V., Malaguarnera M., Basile F., Drago F., Bertino G.
BMC Surg 12 Suppl 1:S7-S7(2012) · Mapped (3)
Chromogranin peptides in amyotrophic lateral sclerosis.
Schrott-Fischer A., Bitsche M., Humpel C., Walcher C., Maier H., Jellinger K., Rabl W., Glueckert R., Marksteiner J.
Regul. Pept. 152:13-21(2009) · Mapped (8)
Chromogranin A and the tumor microenvironment.
Corti A.
Cell. Mol. Neurobiol. 30:1163-1170(2010) · Mapped (3)
Chromogranin A and derived peptides in health and disease.
Loh Y.P., Cheng Y., Mahata S.K., Corti A., Tota B.
J. Mol. Neurosci. 48:347-356(2012) · Mapped (3)
[Expression of chromogranin A in human mammary tissues].
Chen Y.X., Li L.H., Sun J., Wang B., Wang L.X.
Nan Fang Yi Ke Da Xue Xue Bao 30:547-548(2010) · Mapped (3)
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B., Gustafsson B.I., Kidd M., Pavel M., Svejda B., Modlin I.M.
Endocrinol. Metab. Clin. North Am. 40:111-134(2011) · Mapped (3)
Chromogranin A cell density as a diagnostic marker for lymphocytic colitis.
El-Salhy M., Gundersen D., Hatlebakk J.G., Hausken T.
Dig. Dis. Sci. 57:3154-3159(2012) · Mapped (3)
Chromogranin A polymorphisms are associated with hypertensive renal disease.
Salem R.M., Cadman P.E., Chen Y., Rao F., Wen G., Hamilton B.A., Rana B.K., Smith D.W., Stridsberg M., Ward H.J. et al.
J. Am. Soc. Nephrol. 19:600-614(2008) · Mapped (6)
Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors.
Warner R.R., Curran T., Shafir M.K., Schiano T.D., Khaitova V., Kim M.K.
Pancreas 40:622-626(2011) · Mapped (3)
Circadian rhythm of human salivary chromogranin A.
Den R., Toda M., Nagasawa S., Kitamura K., Morimoto K.
Biomed. Res. 28:57-60(2007) · Mapped (3)
Chromogranin A and vesicular monoamine transporter 2 immunolocalization in protein bodies of human locus coeruleus neurons.
Kloukina-Pantazidou I., Chrysanthou-Piterou M., Havaki S., Issidorides M.R.
Ultrastruct Pathol 37:102-109(2013) · Mapped (6)
Chromogranin A: a novel susceptibility gene for essential hypertension.
Sahu B.S., Sonawane P.J., Mahapatra N.R.
Cell. Mol. Life Sci. 67:861-874(2010) · Mapped (3)
Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma.
Kimura N., Yoshida R., Shiraishi S., Pilichowska M., Ohuchi N.
Endocr. Pathol. 13:117-122(2002) · Mapped (6)
Correlation between age and Chromogranin A determination in prostate diseases.
Mearini L., Zucchi A., Scarponi E., Nunzi E., Aglietti M.C., Bini V., Porena M.
Cancer Biomark 10:117-123(2011) · Mapped (3)
Extreme exercise enhances chromogranin A levels correlating with stress levels but not with cardiac burden.
Nickel T., Vogeser M., Emslander I., David R., Heilmeier B., Op den Winkel M., Schmidt-Trucksass A., Wilbert-Lampen U., Hanssen H., Halle M.
Atherosclerosis 220:219-222(2012) · Mapped (3)
Chromogranin A is an autoantigen in type 1 diabetes.
Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F. et al.
Nat. Immunol. 11:225-231(2010) · Mapped (2)
Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients.
Chou W.C., Hung Y.S., Hsu J.T., Chen J.S., Lu C.H., Hwang T.L., Rau K.M., Yeh K.Y., Chen T.C., Sun C.F.
Neuroendocrinology 95:344-350(2012) · Mapped (3)
Comparative effect of finasteride and dutasteride on chromogranin A levels.
Sciarra A., Salciccia S., Nesi G., Cattarino S., Alfarone A., Gentilucci A., Gentile V.
Anticancer Res. 30:4737-4742(2010) · Mapped (3)
Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism.
Seccia T.M., Miotto D., De Toni R., Maniero C., Vincenzi M., Motta R., Pessina A.C., Rossi G.P.
J. Clin. Endocrinol. Metab. 96:E825-9(2011) · Mapped (3)
Plasma chromogranin a in patients with inflammatory bowel disease.
Sciola V., Massironi S., Conte D., Caprioli F., Ferrero S., Ciafardini C., Peracchi M., Bardella M.T., Piodi L.
Inflamm. Bowel Dis. 15:867-871(2009) · Mapped (3)
Serum chromogranin A concentration in hyperthyroidism before and after medical treatment.
Al-Shoumer K.A., Vasanthy B.A.
J. Clin. Endocrinol. Metab. 94:2321-2324(2009) · Mapped (3)
Spatio-temporal expression of chromogranin A during zebrafish embryogenesis.
Xie J., Wang W.Q., Liu T.X., Deng M., Ning G.
J. Endocrinol. 198:451-458(2008) · Mapped (4)
Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
Nunzi M.G., Mugnaini E.
Neuroscience 162:673-687(2009) · Mapped (30)
Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
Donica H., Malecha-Jedraszek A., Stroslawska E., Burska A., Szubstarski F.
Folia Histochem. Cytobiol. 48:603-610(2010) · Mapped (3)7:207-212(2013) · Mapped (3)
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
Biondi A., Malaguarnera G., Vacante M., Berretta M., D’Agata V., Malaguarnera M., Basile F., Drago F., Bertino G.
BMC Surg 12 Suppl 1:S7-S7(2012) · Mapped (3)
Chromogranin peptides in amyotrophic lateral sclerosis.
Schrott-Fischer A., Bitsche M., Humpel C., Walcher C., Maier H., Jellinger K., Rabl W., Glueckert R., Marksteiner J.
Regul. Pept. 152:13-21(2009) · Mapped (8)
Chromogranin A and the tumor microenvironment.
Corti A.
Cell. Mol. Neurobiol. 30:1163-1170(2010) · Mapped (3)
Chromogranin A and derived peptides in health and disease.
Loh Y.P., Cheng Y., Mahata S.K., Corti A., Tota B.
J. Mol. Neurosci. 48:347-356(2012) · Mapped (3)
[Expression of chromogranin A in human mammary tissues].
Chen Y.X., Li L.H., Sun J., Wang B., Wang L.X.
Nan Fang Yi Ke Da Xue Xue Bao 30:547-548(2010) · Mapped (3)
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B., Gustafsson B.I., Kidd M., Pavel M., Svejda B., Modlin I.M.
Endocrinol. Metab. Clin. North Am. 40:111-134(2011) · Mapped (3)
Chromogranin A cell density as a diagnostic marker for lymphocytic colitis.
El-Salhy M., Gundersen D., Hatlebakk J.G., Hausken T.
Dig. Dis. Sci. 57:3154-3159(2012) · Mapped (3)
Chromogranin A polymorphisms are associated with hypertensive renal disease.
Salem R.M., Cadman P.E., Chen Y., Rao F., Wen G., Hamilton B.A., Rana B.K., Smith D.W., Stridsberg M., Ward H.J. et al.
J. Am. Soc. Nephrol. 19:600-614(2008) · Mapped (6)
Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors.
Warner R.R., Curran T., Shafir M.K., Schiano T.D., Khaitova V., Kim M.K.
Pancreas 40:622-626(2011) · Mapped (3)
Circadian rhythm of human salivary chromogranin A.
Den R., Toda M., Nagasawa S., Kitamura K., Morimoto K.
Biomed. Res. 28:57-60(2007) · Mapped (3)
Chromogranin A and vesicular monoamine transporter 2 immunolocalization in protein bodies of human locus coeruleus neurons.
Kloukina-Pantazidou I., Chrysanthou-Piterou M., Havaki S., Issidorides M.R.
Ultrastruct Pathol 37:102-109(2013) · Mapped (6)
Chromogranin A: a novel susceptibility gene for essential hypertension.
Sahu B.S., Sonawane P.J., Mahapatra N.R.
Cell. Mol. Life Sci. 67:861-874(2010) · Mapped (3)
Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma.
Kimura N., Yoshida R., Shiraishi S., Pilichowska M., Ohuchi N.
Endocr. Pathol. 13:117-122(2002) · Mapped (6)
Correlation between age and Chromogranin A determination in prostate diseases.
Mearini L., Zucchi A., Scarponi E., Nunzi E., Aglietti M.C., Bini V., Porena M.
Cancer Biomark 10:117-123(2011) · Mapped (3)
Extreme exercise enhances chromogranin A levels correlating with stress levels but not with cardiac burden.
Nickel T., Vogeser M., Emslander I., David R., Heilmeier B., Op den Winkel M., Schmidt-Trucksass A., Wilbert-Lampen U., Hanssen H., Halle M.
Atherosclerosis 220:219-222(2012) · Mapped (3)
Chromogranin A is an autoantigen in type 1 diabetes.
Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F. et al.
Nat. Immunol. 11:225-231(2010) · Mapped (2)
Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients.
Chou W.C., Hung Y.S., Hsu J.T., Chen J.S., Lu C.H., Hwang T.L., Rau K.M., Yeh K.Y., Chen T.C., Sun C.F.
Neuroendocrinology 95:344-350(2012) · Mapped (3)
Comparative effect of finasteride and dutasteride on chromogranin A levels.
Sciarra A., Salciccia S., Nesi G., Cattarino S., Alfarone A., Gentilucci A., Gentile V.
Anticancer Res. 30:4737-4742(2010) · Mapped (3)
Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism.
Seccia T.M., Miotto D., De Toni R., Maniero C., Vincenzi M., Motta R., Pessina A.C., Rossi G.P.
J. Clin. Endocrinol. Metab. 96:E825-9(2011) · Mapped (3)
Plasma chromogranin a in patients with inflammatory bowel disease.
Sciola V., Massironi S., Conte D., Caprioli F., Ferrero S., Ciafardini C., Peracchi M., Bardella M.T., Piodi L.
Inflamm. Bowel Dis. 15:867-871(2009) · Mapped (3)
Serum chromogranin A concentration in hyperthyroidism before and after medical treatment.
Al-Shoumer K.A., Vasanthy B.A.
J. Clin. Endocrinol. Metab. 94:2321-2324(2009) · Mapped (3)
Spatio-temporal expression of chromogranin A during zebrafish embryogenesis.
Xie J., Wang W.Q., Liu T.X., Deng M., Ning G.
J. Endocrinol. 198:451-458(2008) · Mapped (4)
Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
Nunzi M.G., Mugnaini E.
Neuroscience 162:673-687(2009) · Mapped (30)
Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
Donica H., Malecha-Jedraszek A., Stroslawska E., Burska A., Szubstarski F.
Folia Histochem. Cytobiol. 48:603-610(2010) · Mapped (3)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: